⌘K
Loading ticker…
As of 2026-08-24, Cytosorbents Corp. (CTSO) has a 3-month relative strength percentile of 20 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 37. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 9.6%, relative volume 1.75×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
CTSO is in a stage 4 downtrend, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -4.4% / -36.1%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
CTSO appears in 1 ETF as of May 2026: MSSM at 0.00% weight, $11K notional.
Held by 4 ETFs · $1M across latest filings · largest weight 0.01% (IWC).
Top 1 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| MSSM | 0.00% | $11K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CTSO Jan avg: 21.13% median: 4.50% win: 50% σ: 43.01% n: 4 2022-04-12 → 2026-07-31 | CTSO Feb avg: 6.89% median: 6.58% win: 75% σ: 10.05% n: 4 2022-04-12 → 2026-07-31 | CTSO Mar avg: -5.48% median: -3.30% win: 25% σ: 14.30% n: 4 2022-04-12 → 2026-07-31 | CTSO Apr avg: -12.43% median: -14.74% win: 40% σ: 16.44% n: 5 2022-04-12 → 2026-07-31 | CTSO May avg: -2.42% median: -8.09% win: 40% σ: 17.85% n: 5 2022-04-12 → 2026-07-31 | CTSO Jun avg: 8.20% median: 13.47% win: 60% σ: 31.90% n: 5 2022-04-12 → 2026-07-31 | CTSO Jul avg: 7.43% median: -0.56% win: 40% σ: 38.34% n: 5 2022-04-12 → 2026-07-31 | CTSO Aug avg: -11.48% median: -14.58% win: 25% σ: 16.30% n: 4 2022-04-12 → 2026-07-31 (current) | CTSO Sep avg: -3.42% median: -14.06% win: 25% σ: 33.34% n: 4 2022-04-12 → 2026-07-31 | CTSO Oct avg: -7.04% median: -16.49% win: 25% σ: 30.68% n: 4 2022-04-12 → 2026-07-31 | CTSO Nov avg: -12.28% median: -13.02% win: 25% σ: 13.36% n: 4 2022-04-12 → 2026-07-31 | CTSO Dec avg: -6.04% median: -6.84% win: 25% σ: 13.07% n: 4 2022-04-12 → 2026-07-31 |